Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

M.D. Anderson Cancer Center to guide arglabin preclinical studies

Jan. 18, 2000

Matrix completes patient enrollment in pivotal head and neck cancer trials

Jan. 17, 2000

Nippon Kayaku devotes significant resources to the fight against cancer

Jan. 17, 2000

Porphyrin-based agents for PDT and MRI designed at Schering AG

Jan. 17, 2000

Kinase-inhibitory antiproliferative indolones in development at Boehringer Ingelheim

Jan. 17, 2000

Mechanism of MDR reversal by TER-199 under investigation

Jan. 14, 2000

Access files IND for amlexanox oral rinse

Jan. 14, 2000

ImClone Systems achieves milestone in IMC-C225 collaboration with Merck KGaA

Jan. 13, 2000

Cephalon's CEP-701 enters phase II trials in prostate cancer

Jan. 13, 2000

FDA to review Aptosyn NDA without ODAC input

Jan. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...